Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
emtricitabine (emtriva) (5 trials)
tenofovir (viread) (1 trial)
Fibrosis (Phase 4)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 4)
Hepatitis B, Chronic (Phase 4)
Liver Cirrhosis (Phase 4)
Trials (5 total)
Trial APIs (2 total)